These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 29738662)

  • 21. A broad range of mutations in HIV-1 neutralizing human monoclonal antibodies specific for V2, V3, and the CD4 binding site.
    Li L; Wang XH; Williams C; Volsky B; Steczko O; Seaman MS; Luthra K; Nyambi P; Nadas A; Giudicelli V; Lefranc MP; Zolla-Pazner S; Gorny MK
    Mol Immunol; 2015 Aug; 66(2):364-74. PubMed ID: 25965315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein evolution with an expanded genetic code.
    Liu CC; Mack AV; Tsao ML; Mills JH; Lee HS; Choe H; Farzan M; Schultz PG; Smider VV
    Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17688-93. PubMed ID: 19004806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.
    Artan M; Karadeniz F; Karagozlu MZ; Kim MM; Kim SK
    Carbohydr Res; 2010 Mar; 345(5):656-62. PubMed ID: 20117763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.
    Gombos RB; Kolodkin-Gal D; Eslamizar L; Owuor JO; Mazzola E; Gonzalez AM; Korioth-Schmitz B; Gelman RS; Montefiori DC; Haynes BF; Schmitz JE
    J Virol; 2015 Aug; 89(15):7813-28. PubMed ID: 25995259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
    Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
    PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
    Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
    J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.
    Young KR; Teal BE; Brooks Y; Green TD; Bower JF; Ross TM
    AIDS Res Hum Retroviruses; 2004 Nov; 20(11):1259-68. PubMed ID: 15588348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
    Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
    J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies.
    Shen G; Upadhyay C; Zhang J; Pan R; Zolla-Pazner S; Kong XP; Hioe CE
    PLoS One; 2015; 10(10):e0141233. PubMed ID: 26491873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GP120: target for neutralizing HIV-1 antibodies.
    Pantophlet R; Burton DR
    Annu Rev Immunol; 2006; 24():739-69. PubMed ID: 16551265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly conserved HIV-1 gp120 glycans proximal to CD4-binding region affect viral infectivity and neutralizing antibody induction.
    Huang X; Jin W; Hu K; Luo S; Du T; Griffin GE; Shattock RJ; Hu Q
    Virology; 2012 Feb; 423(1):97-106. PubMed ID: 22192629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
    Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
    Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
    J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1.
    Dey AK; Griffiths C; Lea SM; James W
    RNA; 2005 Jun; 11(6):873-84. PubMed ID: 15923374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated polyester interactions with the CD4 molecule and with the third variable loop domain (v3) of gp120 are chemically distinct.
    Lederman S; Bergmann JE; Cleary AM; Yellin MJ; Fusco PJ; Chess L
    AIDS Res Hum Retroviruses; 1992 Sep; 8(9):1599-610. PubMed ID: 1457206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV.
    Balzarini J
    Lancet Infect Dis; 2005 Nov; 5(11):726-31. PubMed ID: 16253890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency.
    Cai CX; Doria-Rose NA; Schneck NA; Ivleva VB; Tippett B; Shadrick WR; O'Connell S; Cooper JW; Schneiderman Z; Zhang B; Gowetski DB; Blackstock D; Demirji J; Lin BC; Gorman J; Liu T; Li Y; McDermott AB; Kwong PD; Carlton K; Gall JG; Lei QP
    Sci Rep; 2022 May; 12(1):8433. PubMed ID: 35589938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.
    Clayton R; Hardman J; LaBranche CC; McReynolds KD
    Bioconjug Chem; 2011 Oct; 22(10):2186-97. PubMed ID: 21859137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of interaction between sulfated polysaccharides and HIV oligopeptides by surface plasmon resonance.
    Battulga T; Tumurbaatar O; Ganzorig O; Ishimura T; Kanamoto T; Nakashima H; Miyazaki K; Yoshida T
    Int J Biol Macromol; 2019 Mar; 125():909-914. PubMed ID: 30521896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody.
    Hoffhines AJ; Damoc E; Bridges KG; Leary JA; Moore KL
    J Biol Chem; 2006 Dec; 281(49):37877-87. PubMed ID: 17046811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.